327 related articles for article (PubMed ID: 14966562)
1. Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease.
Chan IT; Kutok JL; Williams IR; Cohen S; Kelly L; Shigematsu H; Johnson L; Akashi K; Tuveson DA; Jacks T; Gilliland DG
J Clin Invest; 2004 Feb; 113(4):528-38. PubMed ID: 14966562
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic K-ras in mouse models of myeloproliferative disease and acute myeloid leukemia.
Chan IT; Gilliland DG
Cell Cycle; 2004 May; 3(5):536-7. PubMed ID: 15020845
[TBL] [Abstract][Full Text] [Related]
3. Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus.
Li Q; Haigis KM; McDaniel A; Harding-Theobald E; Kogan SC; Akagi K; Wong JC; Braun BS; Wolff L; Jacks T; Shannon K
Blood; 2011 Feb; 117(6):2022-32. PubMed ID: 21163920
[TBL] [Abstract][Full Text] [Related]
4. FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model.
Kelly LM; Liu Q; Kutok JL; Williams IR; Boulton CL; Gilliland DG
Blood; 2002 Jan; 99(1):310-8. PubMed ID: 11756186
[TBL] [Abstract][Full Text] [Related]
5. Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder.
Braun BS; Tuveson DA; Kong N; Le DT; Kogan SC; Rozmus J; Le Beau MM; Jacks TE; Shannon KM
Proc Natl Acad Sci U S A; 2004 Jan; 101(2):597-602. PubMed ID: 14699048
[TBL] [Abstract][Full Text] [Related]
6. Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice.
MacKenzie KL; Dolnikov A; Millington M; Shounan Y; Symonds G
Blood; 1999 Mar; 93(6):2043-56. PubMed ID: 10068678
[TBL] [Abstract][Full Text] [Related]
7. Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease.
Wahlstrom AM; Cutts BA; Karlsson C; Andersson KM; Liu M; Sjogren AK; Swolin B; Young SG; Bergo MO
Blood; 2007 Jan; 109(2):763-8. PubMed ID: 16973961
[TBL] [Abstract][Full Text] [Related]
8. Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model.
Li L; Piloto O; Nguyen HB; Greenberg K; Takamiya K; Racke F; Huso D; Small D
Blood; 2008 Apr; 111(7):3849-58. PubMed ID: 18245664
[TBL] [Abstract][Full Text] [Related]
9. STAT3 supports experimental K-RasG12D-induced murine myeloproliferative neoplasms dependent on serine phosphorylation.
Gough DJ; Marié IJ; Lobry C; Aifantis I; Levy DE
Blood; 2014 Oct; 124(14):2252-61. PubMed ID: 25150294
[TBL] [Abstract][Full Text] [Related]
10. DNMT3A Haploinsufficiency Transforms FLT3ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia.
Meyer SE; Qin T; Muench DE; Masuda K; Venkatasubramanian M; Orr E; Suarez L; Gore SD; Delwel R; Paietta E; Tallman MS; Fernandez H; Melnick A; Le Beau MM; Kogan S; Salomonis N; Figueroa ME; Grimes HL
Cancer Discov; 2016 May; 6(5):501-15. PubMed ID: 27016502
[TBL] [Abstract][Full Text] [Related]
11. Constitutive MAP kinase activation in hematopoietic stem cells induces a myeloproliferative disorder.
Chung E; Hsu CL; Kondo M
PLoS One; 2011; 6(12):e28350. PubMed ID: 22164275
[TBL] [Abstract][Full Text] [Related]
12. Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice.
Kharas MG; Okabe R; Ganis JJ; Gozo M; Khandan T; Paktinat M; Gilliland DG; Gritsman K
Blood; 2010 Feb; 115(7):1406-15. PubMed ID: 20008787
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic K-ras cooperates with PML-RAR alpha to induce an acute promyelocytic leukemia-like disease.
Chan IT; Kutok JL; Williams IR; Cohen S; Moore S; Shigematsu H; Ley TJ; Akashi K; Le Beau MM; Gilliland DG
Blood; 2006 Sep; 108(5):1708-15. PubMed ID: 16675706
[TBL] [Abstract][Full Text] [Related]
14. The Tel-PDGFRbeta fusion gene produces a chronic myeloproliferative syndrome in transgenic mice.
Ritchie KA; Aprikyan AA; Bowen-Pope DF; Norby-Slycord CJ; Conyers S; Bartelmez S; Sitnicka EH; Hickstein DD
Leukemia; 1999 Nov; 13(11):1790-803. PubMed ID: 10557054
[TBL] [Abstract][Full Text] [Related]
15. Somatic activation of a conditional KrasG12D allele causes ineffective erythropoiesis in vivo.
Braun BS; Archard JA; Van Ziffle JA; Tuveson DA; Jacks TE; Shannon K
Blood; 2006 Sep; 108(6):2041-4. PubMed ID: 16720837
[TBL] [Abstract][Full Text] [Related]
16. Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity.
Wang J; Farkas C; Benyoucef A; Carmichael C; Haigh K; Wong N; Huylebroeck D; Stemmler MP; Brabletz S; Brabletz T; Nefzger CM; Goossens S; Berx G; Polo JM; Haigh JJ
PLoS Biol; 2021 Sep; 19(9):e3001394. PubMed ID: 34550965
[TBL] [Abstract][Full Text] [Related]
17. The human GFI136N variant induces epigenetic changes at the Hoxa9 locus and accelerates K-RAS driven myeloproliferative disorder in mice.
Khandanpour C; Krongold J; Schütte J; Bouwman F; Vassen L; Gaudreau MC; Chen R; Calero-Nieto FJ; Diamanti E; Hannah R; Meyer SE; Grimes HL; van der Reijden BA; Jansen JH; Patel CV; Peeters JK; Löwenberg B; Dührsen U; Göttgens B; Möröy T
Blood; 2012 Nov; 120(19):4006-17. PubMed ID: 22932805
[TBL] [Abstract][Full Text] [Related]
18. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow.
Pear WS; Miller JP; Xu L; Pui JC; Soffer B; Quackenbush RC; Pendergast AM; Bronson R; Aster JC; Scott ML; Baltimore D
Blood; 1998 Nov; 92(10):3780-92. PubMed ID: 9808572
[TBL] [Abstract][Full Text] [Related]
19. Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis.
Loberg MA; Bell RK; Goodwin LO; Eudy E; Miles LA; SanMiguel JM; Young K; Bergstrom DE; Levine RL; Schneider RK; Trowbridge JJ
Leukemia; 2019 Jul; 33(7):1635-1649. PubMed ID: 30692594
[TBL] [Abstract][Full Text] [Related]
20. Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis.
Chang YI; You X; Kong G; Ranheim EA; Wang J; Du J; Liu Y; Zhou Y; Ryu MJ; Zhang J
Leukemia; 2015 Sep; 29(9):1847-56. PubMed ID: 25801914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
